Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novanta (NOVT) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Novanta (NOVT) over the last 17 years, with Q3 2025 value amounting to $1.5 billion.

  • Novanta's Liabilities and Shareholders Equity rose 613.1% to $1.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.8 billion, marking a year-over-year increase of 617.53%. This contributed to the annual value of $1.4 billion for FY2024, which is 1325.02% up from last year.
  • Latest data reveals that Novanta reported Liabilities and Shareholders Equity of $1.5 billion as of Q3 2025, which was up 613.1% from $1.5 billion recorded in Q2 2025.
  • In the past 5 years, Novanta's Liabilities and Shareholders Equity registered a high of $1.5 billion during Q2 2025, and its lowest value of $852.3 million during Q2 2021.
  • Moreover, its 5-year median value for Liabilities and Shareholders Equity was $1.2 billion (2021), whereas its average is $1.3 billion.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first skyrocketed by 4192.24% in 2021, then tumbled by 178.19% in 2025.
  • Over the past 5 years, Novanta's Liabilities and Shareholders Equity (Quarter) stood at $1.2 billion in 2021, then grew by 1.09% to $1.2 billion in 2022, then decreased by 1.22% to $1.2 billion in 2023, then rose by 13.25% to $1.4 billion in 2024, then increased by 8.45% to $1.5 billion in 2025.
  • Its last three reported values are $1.5 billion in Q3 2025, $1.5 billion for Q2 2025, and $1.4 billion during Q1 2025.